| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Pemphigus | |||||
| 2 | More general conditions related to this trial | ||||
| Autoimmune Diseases | |||||
| Immune System Diseases | |||||
| Skin Diseases | |||||
| Skin Diseases, Vesiculobullous | |||||
| 3 | Additional drug interventions recognized in this trial | ||||
| Dexamethasone | |||||
| Dexamethasone acetate | |||||
| 4 | More general drug interventions related to this trial | ||||
| Anti-Inflammatory Agents | |||||
| Antiemetics | |||||
| Antineoplastic Agents | |||||
| Antineoplastic Agents, Hormonal | |||||
| Autonomic Agents | |||||
| Central Nervous System Agents | |||||
| Gastrointestinal Agents | |||||
| Glucocorticoids | |||||
| Hormones | |||||
| Hormones, Hormone Substitutes, and Hormone Antagonists | |||||
| Peripheral Nervous System Agents | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Therapeutic Uses | |||||
| 5 | Sponsors listed in this trial | ||||
| University Medical Centre Groningen | |||||
|
